D-0717-2022 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-0717-2022 was initiated by Akorn, Inc. on Sep 8, 2021 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Sep 28, 2023). Affected quantity: 62,331 box.

Recall details

Product Type
Drugs
Report Date
Mar 30, 2022
Initiation Date
Sep 8, 2021
Termination Date
Sep 28, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
62,331 box

Product description

TheraTears Extra (sodium carboxymethylcellulose) 0.25% Lubricant Eye Drops, 30 Sterile Single-Use Vials per box, Akorn Consumer Health, A Division of Akorn, Inc., Ann Arbor, MI 48105. NDC 58790-010-30

Reason for recall

Lack of Assurance of Sterility

Distribution pattern

Nationwide within theUSA

Code information

Lot #: 913012, 913013, 913014, Exp. Date 1/31/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0717-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0717-2022. Report a data issue: hello@regdatalab.com.